Kaposi sarcoma associated herpesvirus gene function
AssigneeThe Regents of the University of California
InventorsFenyong Liu, Adam Smith, Marco Paliza-Carre, Rachael Burchfield
Life of this patent
Estimating the term…
Loading patent…
AssigneeThe Regents of the University of California
InventorsFenyong Liu, Adam Smith, Marco Paliza-Carre, Rachael Burchfield
Estimating the term…
Kaposi's sarcoma-associated herpesvirus (KSHV) is an opportunistic pathogen causing Kaposi's sarcoma. It is capable of establishing latent infection, which can be reactivated to engage lytic infection for progeny production. KSHV contains a ˜165 kilobase DNA genome predicted to encode at least 90 open reading frames (ORFs). In this report, we generated 91 KSHV mutants, each characterized by the disruption of a single viral ORF. The growth of these mutants in cultured cells was examined to systematically investigate the necessity of each ORF for viral latency, reactivation, and lytic replication. Salient aspects are (a) 44 ORFs are essential for viral lytic replication in cultured cells and 47 are nonessential; (b) KSHV reactivation can be positively or negatively regulated by specific viral ORFs; and (c) ORFs identified to regulate viral reactivation encode functions modulating both innate and adaptive immune responses. The intersection of viral immunomodulatory genes controlling reactivation suggests that KSHV engages in a concerted effort to communicate and respond to the host immune system for reactivation and replication using a viral sensory network. Our results imply a novel mechanism in which reactivation of KSHV is actively controlled by the virus in response to its surrounding environment, leading to the opportunistic nature of viral diseases that are strongly correlated to the host's immune status and conditions.
A Kaposi sarcoma associated herpesvirus (KSHV) mutant with inactivation or deletion of one or more of the open reading frames (ORFs) disclosed in Table 1.
An artificial gene, such as protein expression plasmids, or gene product thereof, the gene comprising one of the KSHV essential or nonessential genes disclosed in Table 1, particularly the 27 new identified essential genes, as disclosed.
An opportunistic factor that functions to suppress KSHV spontaneous reactivation, for use in the treatment of KSHV infection, as disclosed.
Dependencies are inferred from the claim text.